Mepe, the gene encoding a tumor-secreted protein in oncogenic hypophosphatemic osteomalacia, is expressed in bone

L Argiro1, M Desbarats, F H Glorieux

  • 1Genetics Unit, Shriners Hospital, Montreal, Quebec, H3G 1A6, Canada.

Genomics
|June 21, 2001
PubMed

Insights

Matrix extracellular phosphoglycoprotein (MEPE) is linked to oncogenic hypophosphatemic osteomalacia. This study identifies the murine MEPE homolog and shows its increased expression during bone mineralization in X-linked hypophosphatemia models.

Area of Science:

  • Biochemistry
  • Genetics
  • Molecular Biology

Background:

  • The matrix extracellular phosphoglycoprotein (MEPE) gene is a candidate for the phosphaturic factor in oncogenic hypophosphatemic osteomalacia (OHO).
  • X-linked hypophosphatemia (XLH) shares similarities with OHO and involves mutations in PHEX, a metallopeptidase regulating phosphate homeostasis.
  • PHEX is believed to process factors affecting bone mineralization and renal phosphate reabsorption.

Purpose of the Study:

  • To isolate and characterize the murine homolog of the MEPE gene.
  • To investigate the expression pattern of Mepe in osteoblasts and its association with mineralization.
  • To examine Mepe expression in the murine model of XLH (Hyp mice).

Main Methods:

  • Isolation of the murine MEPE homolog from a bone cDNA library.
  • Analysis of Mepe protein and mRNA expression in osteoblasts.
  • Comparison of Mepe expression in normal and Hyp mice.

Main Results:

  • The murine MEPE homolog encodes a 433-amino acid protein, 92 amino acids shorter than human MEPE.
  • Mepe is expressed by differentiated osteoblasts and down-regulated by 1,25-(OH)2D3.
  • Mepe expression increases during osteoblast-mediated matrix mineralization, and elevated mRNA levels are found in Hyp mice.

Conclusions:

  • MEPE/Mepe is expressed by osteoblasts in association with mineralization.
  • This finding provides a link between MEPE and the pathophysiology of hypophosphatemic disorders.
  • Further research into MEPE's role could elucidate mechanisms of phosphate regulation and bone mineralization.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...